3M Drug Delivery Systems appoints new president and general manager

Cindy Kent named President and General Manager of 3M Drug Delivery Systems

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

3M Drug Delivery Systems announces the appointment of Cindy R. Kent as its new president and general manager. She succeeds James Ingebrand, who was recently named president and general manager of 3M ESPE, 3M’s dental division.

Kent most recently served as the Vice President of Strategy, Business Development and US Medical Key Accounts for 3M Healthcare. Prior to joining 3M, she was Vice President and General Manager of the Gastro/Urology Therapies Business Unit of Medtronic, Inc. and has held a number of roles at Eli Lilly in manufacturing, human resources, sales, and marketing, giving her broad expertise in the pharmaceutical and medical device industries.

“In this new role, I’m excited to have a wealth of feedback from our customers on which we can base our vision and work towards future opportunities,” said Kent. “Customers have let us know that they feel we add value because of our outstanding quality and our technical expertise, both in manufacturing and on the scientific front, and I want to continue building on that trusted reputation.”

Kent is a 2013 Aspen Institute Henry Crown Fellow. She holds a B.S. degree in Industrial Engineering and Management Science from Northwestern University, as well as an M.B.A. in Marketing and a Master’s in Divinity, both from Vanderbilt University.
For more information about 3M Drug Delivery Systems, visit www.3M.com/dds.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?